Search Results

Patient (or carer) Initiated Follow-up SOP Dementia Palliative Care Service (S132)

Patient initiated follow-up (PIFU) describes when a patient (or their carer) can initiate their follow-up visit as and when required, e.g., when symptoms or circumstances change. This SOP defines the process, roles, and responsibilities for the following: • Identifying which patients PIFU is right for • Moving a patient onto a PIFU pathway • Booking visits which have been initiated by a patient or carer • Managing patients who do not initiate a review/home visit within the PIFU timescale • Discharging or booking reviews at the end of that patient’s PIFU timescale • Monitoring compliance Dementia Palliative Care Service are in the process of piloting a PIFU process for 12 months. The pilot will be reviewed every 3 months with a final review post 12 months.

A2 - Duty of Candour Letter Template (P81)

Duty of Candour Letter Template

Final Standard Operating Procedure Safe Staffing Levels and Annual Leave management ISHS October 2025

Disclosure Ref 2025218 - Vehicle fleet list operated by the Trust, whether owned or leased.doc

Freedom of information disclosure relating to vehicle fleet list operated by the Trust, whether owned or leased

Disclosure Ref 2025262- Damp and mould health related conditions January 2022 to January 2025.doc

Freedom of information request relating to yearly figures (2022–2024) on diagnoses, admissions, and deaths related to damp‑ and mould‑associated conditions—including aspergillosis, hypersensitivity pneumonitis, and allergic bronchopulmonary aspergillosis—within the period 1 January 2022 to 1 January 2025.

Disclosure Ref 2025338 - Digital dictation.doc

Freedom of information disclosure relating to digital dictation

Disclosure Ref 2025304 - Patient deaths whilst waiting for consultant led elective hospital treatment.docx

Freedom of information disclosure relating to the number of patients who died whilst on the waiting list for consultant‑led elective hospital treatment, including breakdowns by wait time, ethnicity, religion, year, and (in some cases) postcode district

Disclosure Ref 2025207 - Patients treated with Curosurf and Peyona.doc

Freedom of information request relating to how many unique patients in your trust were treated with Curosurf or Peyona

Unopposed-declaration-Public-BolsoverChesterfieldandNorthEastDerbyshire.pdf

Unopposed-declaration-Public-BolsoverChesterfieldandNorthEastDerbyshire

A2 - Control Drugs Authorised Signatory Record Sheet - Authorised Staff Members (S47)

Control Drugs Authorised Signatory Record Sheet - Authorised Staff Members